Author:
Sherstoboev E. Yu.,Oleinik L. A.,Zhdanov V. V.,Kikhtenko N. A.,Madonov P. G.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference14 articles.
1. Grigoryan SS. Interferon lambda (type 3 interferons) and viral infections. Interferon — 2011. Ershova FI, Narovlyansky AN, eds. Moscow, 2012. P. 63-72. Russian.
2. Karkischenko NN, Khoron’ko VV, Sergeeva SA, Karkischenko VN. Pharmacokinetics. Dolzhich GI, ed. Rostov-on-Don, 2001. Russian.
3. Kikhtenko NA, Ilyicheva TN, Durymanov AG, Fursova AZh, Madonov PG. Investigation of the antiviral activity of the recombinant human interferon lambda 1 in human conjunctiva cell culture. Sib. Nauch. Med. Zh. 2021;41(5):31-36. doi: https://doi.org/10.18699/SSMJ20210504.Russian.
4. Madonov PG, Kikhtenko NA, Oleinik LA, Udut VV. Interferon Lambda — the new representative of pharmacologically active interferons. Eksp. Klin. Farmakol. 2020;83(6):30-37. doi: https://doi.org/10.30906/0869-2092-2020-83-6-30-37.Russian.
5. Madonov PG, Svyatchenko VA, Legostaev SS, Kikhtenko NA, Kotlyarova AA, Oleinik LA, Baikalov GI. Evaluation of the Anti-Viral Activity of Human Recombinant Interferon Lambda-1 against SARS-CoV-2. Bull. Exp. Biol. Med. 2021;172(1):53-56. doi: https://doi.org/10.1007/s10517-021-05330-0